share_log
Reuters ·  Mar 31 13:24
Connect Biopharma Holdings Ltd - Phase 2 Trials for Rademikibart to Start in 2Q 2025, Data Expected in H2 2026 - SEC Filing
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 202

Recommended

Write a comment